While selloffs can be painful in the short term, markets tend to bounce back. Historically, the ASX has recovered from every ...

Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through ...

Morgan Stanley began coverage on shares of ResMed (NYSE:RMD – Free Report) in a research note issued to investors on Wednesday, MarketBeat reports. The firm issued an overweight rating and a $280.00 ...

A recent Global Sleep Survey from health technology company ResMed, meanwhile, found that 50% of Americans opt to sleep apart ...

Morgan Stanley analyst David Bailey initiated coverage of ResMed (RMD) with an Overweight rating and $280 price target The ...

With a market cap of $32.6 billion, San Diego, California-based ResMed Inc. (RMD) is a global leader in designing, ...

Independent Advisor Alliance acquired a new stake in shares of ResMed Inc. (NYSE:RMD – Free Report) during the fourth quarter ...

Shares rise, new job creation undercuts forecasts; Morgan Stanley downgrades NAB; Nanosonics rallies; Fed sees “transitory” ...

CPAP therapy significantly reduces the risk of death for people with obstructive sleep apnea, according to a landmark meta-analysis supported by Resmed and published in The Lancet Respiratory Medicine ...

If you’ve reached a point in life where you are in search of hacks that help you get a good night’s sleep, then take a look ...

Resmed (RMD) announced the publication of a meta-analysis in The Lancet Respiratory Medicine, demonstrating that CPAP therapy significantly ...

Citi analyst Mathieu Chevrier maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD – Research ...